Amphastar Pharmaceuticals Inc (AMPH)
39.42
+0.79
(+2.05%)
USD |
NASDAQ |
Apr 19, 12:52
Amphastar Pharmaceuticals Cash and Short Term Investments (Quarterly): 256.81M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 256.81M |
| September 30, 2023 | 299.88M |
| June 30, 2023 | 163.14M |
| March 31, 2023 | 192.89M |
| December 31, 2022 | 175.76M |
| September 30, 2022 | 184.09M |
| June 30, 2022 | 183.39M |
| March 31, 2022 | 187.01M |
| December 31, 2021 | 136.67M |
| September 30, 2021 | 114.63M |
| June 30, 2021 | 117.18M |
| March 31, 2021 | 115.13M |
| December 31, 2020 | 105.62M |
| September 30, 2020 | 98.78M |
| June 30, 2020 | 98.49M |
| March 31, 2020 | 67.05M |
| December 31, 2019 | 85.36M |
| September 30, 2019 | 98.28M |
| June 30, 2019 | 123.21M |
| March 31, 2019 | 81.93M |
| December 31, 2018 | 89.17M |
| Date | Value |
|---|---|
| September 30, 2018 | 71.56M |
| June 30, 2018 | 50.89M |
| March 31, 2018 | 57.37M |
| December 31, 2017 | 68.23M |
| September 30, 2017 | 69.44M |
| June 30, 2017 | 83.27M |
| March 31, 2017 | 77.51M |
| December 31, 2016 | 72.88M |
| September 30, 2016 | 67.45M |
| June 30, 2016 | 66.66M |
| March 31, 2016 | 63.33M |
| December 31, 2015 | 66.07M |
| September 30, 2015 | 70.68M |
| June 30, 2015 | 74.46M |
| March 31, 2015 | 68.59M |
| December 31, 2014 | 67.83M |
| September 30, 2014 | 72.88M |
| June 30, 2014 | 64.08M |
| March 31, 2014 | 52.14M |
| December 31, 2013 | 53.59M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
67.05M
Minimum
Mar 2020
299.88M
Maximum
Sep 2023
147.55M
Average
123.21M
Median
Jun 2019
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly and Co | 2.928B |
| Dentsply Sirona Inc | 334.00M |
| Pacira BioSciences Inc | 278.58M |
| Organon & Co | 693.00M |
| NovaBay Pharmaceuticals Inc | 3.13M |